Showing results (2001-2010 of 2,046) with videos related to

Sort By:
Pageof 205
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.
Radiation Research|August 20, 2025
Multicentered Biospecimen Analyses after 4 Gy Sublethal Total Body Irradiation in RhesusJ Tyson McDonald, Claude J Rogers, Denise Nishita, et al.
Internal Medicine Journal|November 14, 2024
Environmental impact of large language models in medicineOliver Kleinig, Shreyans Sinhal, Rushan Khurram, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 5, 2022
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, et al.
Science (New York, N.Y.)|August 3, 2019
Bright and photostable chemigenetic indicators for extended in vivo voltage imagingAhmed S Abdelfattah, Takashi Kawashima, Amrita Singh, et al.
Brain & Spine|June 30, 2025
A core outcome set for cranioplasty following stroke or traumatic brain injury - The COAST studyH Mee, T K Korhonen, A M Castaño-Leon, et al.
Cancer Discovery|September 22, 2020
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid CancersJavier Pascual, Joline S J Lim, Iain R Macpherson, et al.
JAMA Network Open|August 15, 2022
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical TrialCynthia Portal-Celhay, Eduardo Forleo-Neto, Will Eagan, et al.
The New England Journal of Medicine|December 17, 2020
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
Science Translational Medicine|July 16, 2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancerElias Quijano, Diana Martinez-Saucedo, Zaira Ianniello, et al.
Pageof 205